1. Home
  2. ZION vs RGEN Comparison

ZION vs RGEN Comparison

Compare ZION & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zions Bancorporation N.A.

ZION

Zions Bancorporation N.A.

HOLD

Current Price

$59.61

Market Cap

7.8B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$165.71

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZION
RGEN
Founded
1873
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ZION
RGEN
Price
$59.61
$165.71
Analyst Decision
Hold
Buy
Analyst Count
19
10
Target Price
$60.74
$174.90
AVG Volume (30 Days)
1.4M
630.5K
Earning Date
01-20-2026
10-28-2025
Dividend Yield
3.02%
N/A
EPS Growth
27.47
N/A
EPS
5.59
0.03
Revenue
$3,207,000,000.00
$707,890,000.00
Revenue This Year
$12.03
$17.84
Revenue Next Year
$4.35
$12.44
P/E Ratio
$10.65
$5,365.43
Revenue Growth
6.54
11.74
52 Week Low
$39.32
$102.97
52 Week High
$60.77
$182.52

Technical Indicators

Market Signals
Indicator
ZION
RGEN
Relative Strength Index (RSI) 68.83 56.56
Support Level $58.62 $156.01
Resistance Level $60.77 $167.74
Average True Range (ATR) 1.29 4.38
MACD 0.11 -0.10
Stochastic Oscillator 77.70 75.62

Price Performance

Historical Comparison
ZION
RGEN

About ZION Zions Bancorporation N.A.

Zions Bancorporation is a regional US bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions focuses primarily on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: